Literature DB >> 23458899

Perichondrium phenotype and border function are regulated by Ext1 and heparan sulfate in developing long bones: a mechanism likely deranged in Hereditary Multiple Exostoses.

Julianne Huegel1, Christina Mundy, Federica Sgariglia, Patrik Nygren, Paul C Billings, Yu Yamaguchi, Eiki Koyama, Maurizio Pacifici.   

Abstract

During limb skeletogenesis the cartilaginous long bone anlagen and their growth plates become delimited by perichondrium with which they interact functionally. Yet, little is known about how, despite being so intimately associated with cartilage, perichondrium acquires and maintains its distinct phenotype and exerts its border function. Because perichondrium becomes deranged and interrupted by cartilaginous outgrowths in Hereditary Multiple Exostoses (HME), a pediatric disorder caused by EXT mutations and consequent heparan sulfate (HS) deficiency, we asked whether EXT genes and HS normally have roles in establishing its phenotype and function. Indeed, conditional Ext1 ablation in perichondrium and lateral chondrocytes flanking the epiphyseal region of mouse embryo long bone anlagen - a region encompassing the groove of Ranvier - caused ectopic cartilage formation. A similar response was observed when HS function was disrupted in long bone anlagen explants by genetic, pharmacological or enzymatic means, a response preceded by ectopic BMP signaling within perichondrium. These treatments also triggered excess chondrogenesis and cartilage nodule formation and overexpression of chondrogenic and matrix genes in limb bud mesenchymal cells in micromass culture. Interestingly, the treatments disrupted the peripheral definition and border of the cartilage nodules in such a way that many nodules overgrew and fused with each other into large amorphous cartilaginous masses. Interference with HS function reduced the physical association and interactions of BMP2 with HS and increased the cell responsiveness to endogenous and exogenous BMP proteins. In sum, Ext genes and HS are needed to establish and maintain perichondrium's phenotype and border function, restrain pro-chondrogenic signaling proteins including BMPs, and restrict chondrogenesis. Alterations in these mechanisms may contribute to exostosis formation in HME, particularly at the expense of regions rich in progenitor cells including the groove of Ranvier.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23458899      PMCID: PMC3733121          DOI: 10.1016/j.ydbio.2013.02.008

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  66 in total

Review 1.  All for one and one for all: condensations and the initiation of skeletal development.

Authors:  B K Hall; T Miyake
Journal:  Bioessays       Date:  2000-02       Impact factor: 4.345

Review 2.  Functions of cell surface heparan sulfate proteoglycans.

Authors:  M Bernfield; M Götte; P W Park; O Reizes; M L Fitzgerald; J Lincecum; M Zako
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

3.  Synovial joint formation requires local Ext1 expression and heparan sulfate production in developing mouse embryo limbs and spine.

Authors:  Christina Mundy; Tadashi Yasuda; Takashi Kinumatsu; Yu Yamaguchi; Masahiro Iwamoto; Motomi Enomoto-Iwamoto; Eiki Koyama; Maurizio Pacifici
Journal:  Dev Biol       Date:  2010-12-23       Impact factor: 3.582

4.  Compound heterozygous loss of Ext1 and Ext2 is sufficient for formation of multiple exostoses in mouse ribs and long bones.

Authors:  Beverly M Zak; Manuela Schuksz; Eiki Koyama; Christina Mundy; Dan E Wells; Yu Yamaguchi; Maurizio Pacifici; Jeffrey D Esko
Journal:  Bone       Date:  2011-02-15       Impact factor: 4.398

5.  Perlecan is essential for cartilage and cephalic development.

Authors:  E Arikawa-Hirasawa; H Watanabe; H Takami; J R Hassell; Y Yamada
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

6.  Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT.

Authors:  C E de Andrea; C M A Reijnders; H M Kroon; D de Jong; P C W Hogendoorn; K Szuhai; J V M G Bovée
Journal:  Oncogene       Date:  2011-08-01       Impact factor: 9.867

7.  Hedgehog proteins stimulate chondrogenic cell differentiation and cartilage formation.

Authors:  M Enomoto-Iwamoto; T Nakamura; T Aikawa; Y Higuchi; T Yuasa; A Yamaguchi; T Nohno; S Noji; T Matsuya; K Kurisu; E Koyama; M Pacifici; M Iwamoto
Journal:  J Bone Miner Res       Date:  2000-09       Impact factor: 6.741

8.  Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice.

Authors:  X Lin; G Wei; Z Shi; L Dryer; J D Esko; D E Wells; M M Matzuk
Journal:  Dev Biol       Date:  2000-08-15       Impact factor: 3.582

9.  Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2).

Authors:  Diah S Bramono; Sadasivam Murali; Bina Rai; Ling Ling; Wei Theng Poh; Zophia Xuehui Lim; Gary S Stein; Victor Nurcombe; Andre J van Wijnen; Simon M Cool
Journal:  Bone       Date:  2011-12-28       Impact factor: 4.398

10.  Regulation of skeletal progenitor differentiation by the BMP and retinoid signaling pathways.

Authors:  A D Weston; V Rosen; R A Chandraratna; T M Underhill
Journal:  J Cell Biol       Date:  2000-02-21       Impact factor: 10.539

View more
  31 in total

1.  Epiphyseal abnormalities, trabecular bone loss and articular chondrocyte hypertrophy develop in the long bones of postnatal Ext1-deficient mice.

Authors:  Federica Sgariglia; Maria Elena Candela; Julianne Huegel; Olena Jacenko; Eiki Koyama; Yu Yamaguchi; Maurizio Pacifici; Motomi Enomoto-Iwamoto
Journal:  Bone       Date:  2013-08-17       Impact factor: 4.398

2.  Heparan sulfate antagonism alters bone morphogenetic protein signaling and receptor dynamics, suggesting a mechanism in hereditary multiple exostoses.

Authors:  Christina Mundy; Evan Yang; Hajime Takano; Paul C Billings; Maurizio Pacifici
Journal:  J Biol Chem       Date:  2018-04-05       Impact factor: 5.157

3.  Identification and characterization of a novel heparan sulfate-binding domain in Activin A longest variants and implications for function.

Authors:  Evan Yang; Christina Mundy; Eric F Rappaport; Maurizio Pacifici; Paul C Billings
Journal:  PLoS One       Date:  2019-09-19       Impact factor: 3.240

Review 4.  The pathogenic roles of heparan sulfate deficiency in hereditary multiple exostoses.

Authors:  Maurizio Pacifici
Journal:  Matrix Biol       Date:  2017-12-24       Impact factor: 11.583

5.  Palovarotene Inhibits Osteochondroma Formation in a Mouse Model of Multiple Hereditary Exostoses.

Authors:  Toshihiro Inubushi; Isabelle Lemire; Fumitoshi Irie; Yu Yamaguchi
Journal:  J Bone Miner Res       Date:  2017-11-30       Impact factor: 6.741

Review 6.  Retinoid roles and action in skeletal development and growth provide the rationale for an ongoing heterotopic ossification prevention trial.

Authors:  Maurizio Pacifici
Journal:  Bone       Date:  2017-08-19       Impact factor: 4.398

7.  NFAT restricts osteochondroma formation from entheseal progenitors.

Authors:  Xianpeng Ge; Kelly Tsang; Lizhi He; Roberto A Garcia; Joerg Ermann; Fumitaka Mizoguchi; Minjie Zhang; Bin Zhou; Bin Zhou; Antonios O Aliprantis
Journal:  JCI Insight       Date:  2016-04

8.  Mouse limb skeletal growth and synovial joint development are coordinately enhanced by Kartogenin.

Authors:  Rebekah S Decker; Eiki Koyama; Motomi Enomoto-Iwamoto; Peter Maye; David Rowe; Shoutian Zhu; Peter G Schultz; Maurizio Pacifici
Journal:  Dev Biol       Date:  2014-09-18       Impact factor: 3.582

Review 9.  Fibrodysplasia ossificans progressiva (FOP): A disorder of osteochondrogenesis.

Authors:  Frederick S Kaplan; Mona Al Mukaddam; Alexandra Stanley; O Will Towler; Eileen M Shore
Journal:  Bone       Date:  2020-07-27       Impact factor: 4.398

10.  HIF-1-PHD2 axis controls expression of syndecan 4 in nucleus pulposus cells.

Authors:  Nobuyuki Fujita; Yuichiro Hirose; Cassie M Tran; Kazuhiro Chiba; Takeshi Miyamoto; Yoshiaki Toyama; Irving M Shapiro; Makarand V Risbud
Journal:  FASEB J       Date:  2014-02-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.